drugset / Trial / NCT01084148

Long-term Efficacy and Safety of V0034 CR 01B Cream in Patients With Moderate-to-severe Uremic Xerosis

NCT01084148

Phase 3 Completed 237 enrolled Orfagen
RandomizedParallel-groupDouble-blindTreatment

Summary

Primary objective: To demonstrate the long-term efficacy (response to treatment during initial therapy, time to relapse without treatment, durability and lesional recurrence during maintenance therapy) of V0034 CR 01B cream on uraemic xerosis in the real-life setting. Secondary objectives: 1. To assess the local tolerance of V0034 CR 01B after long-term use 2. To assess the patient benefit and acceptability of V0034 CR 01B

Timeline

Start
2007-01
Primary completion
2009-01
Completion
2009-03

Drugs

EvaluationDrugModalityDoseRoute
Subject V0034CR01B Unknown

Indications

No indication recorded.